Ildong Pharmaceutical said Tuesday that it has signed a distribution and co-promotion agreement with Pﬁzer Korea for Nurtec orally disintegrating tablets (ODT), a novel migraine treatment containing rimegepant.

Nurtec ODT (rimegepant ODT) - Pfizer

Sep 8, 2026